Namma Cytotron Cancer Care Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
as on 24-01-2024
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
About Namma Cytotron Cancer Care Llp
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
- CIN/LLPIN/FCRN
AAS-3754
- Incorporation Date
25 Apr 2020
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Bangalore
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Namma Cytotron Cancer Care Llp?
Designated Partners(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manjunath Kempanna  | Designated Partner | 25-Apr-2020 | Current |
| Raghu More | Designated Partner | 25-Apr-2020 | Current |
| Prashantkumar Algud | Designated Partner | 25-Apr-2020 | Current |
| Vishwas Reddy | Designated Partner | 25-Apr-2020 | Current |
| Ashok Reddy | Designated Partner | 25-Apr-2020 | Current |
Financial Performance of Namma Cytotron Cancer Care Llp.
Enhance accessibility to Namma Cytotron Cancer Care Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Namma Cytotron Cancer Care Llp?
Unlock access to Namma Cytotron Cancer Care Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Namma Homeopathy Private LimitedActive 5 years 5 monthsManjunath Kempanna, Raghu More and 3 more are mutual person
Namma Naturopathy LlpActive 4 years 10 monthsManjunath Kempanna, Raghu More and 1 more are mutual person
- Ayush Health Products LlpActive 3 years 8 months
Manjunath Kempanna and Raghu More are mutual person
- Namma Physiotherapy LlpActive 4 years 10 months
Raghu More, Prashantkumar Algud and 1 more are mutual person
Charges (Loans)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Namma Cytotron Cancer Care Llp?
Namma Cytotron Cancer Care Llp has a workforce of 13 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Namma Cytotron Cancer Care Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Namma Cytotron Cancer Care Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
